Investigation of Potent Lead for Acquired Immunodeficiency Syndrome from Traditional Chinese Medicine
Figure 3
The docking poses of ligands. (a) The crystal structure of VIF and the designed docking site, (b) glutamic acid, (c) plantagoguanidinic acid, and (d) Aurantiamide acetate.
